C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2009
11/05/2009	US20090274688 Antibodies to OPGL
11/05/2009	US20090274687 Attenuation of hypoxia induced cardiovascular disorders
11/05/2009	US20090274680 Human Phospholipases
11/05/2009	US20090274679 Production and use of human butyrylcholinesterase
11/05/2009	US20090274671 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
11/05/2009	US20090274670 Dph2 gene deletion mutant and uses thereof
11/05/2009	US20090274669 Dendritic Cells Transiently Transfected with a Membrane Homing Polypeptide and their use
11/05/2009	US20090274668 Combined Regulation of Neural Cell Production
11/05/2009	US20090274667 Retinal pigment epithelial stem cells
11/05/2009	US20090274666 B7-h1, a novel immunoregulatory molecule
11/05/2009	US20090274665 Stem Cells For Treating Lung Diseases
11/05/2009	US20090274664 Method of culturing vascular smooth muscle cells, culture device and medical material obtained by the culture
11/05/2009	US20090274663 Materials and Methods Relating to Cell Based Therapies
11/05/2009	US20090274630 Red blood cell-derived vesicles as a nanoparticle drug delivery system
11/05/2009	US20090274618 TADG-15: an extracellular serine protease overexpressed in carcinomas
11/05/2009	CA2726007A1 Vaccine compositions and methods
11/05/2009	CA2723197A1 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
11/05/2009	CA2722909A1 Method for collecting functional cells in vivo with high efficiency
11/05/2009	CA2722906A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009	CA2722889A1 New chimeric alpha-amylase variants
11/05/2009	CA2722852A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009	CA2722816A1 Compositions for treating an arthritic condition
11/05/2009	CA2722664A1 Compositions for treating an inflammatory autoimmune condition
11/05/2009	CA2722658A1 Compositions and methods for treating multiple sclerosis
11/05/2009	CA2722061A1 Sessile stem cells
11/05/2009	CA2722044A1 Neural regenerating cells with alterations in dna methylation
11/05/2009	CA2695522A1 Method of nuclear reprogramming
11/05/2009	CA2630510A1 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/04/2009	EP2113569A1 Recombinant adenoviral vector and methods of use
11/04/2009	EP2113568A1 Knock-in mouse for modelling blockade of human TNFalpha
11/04/2009	EP2113565A1 Conductive substrate for nucleic acid delivery and method for delivering nucleic acid
11/04/2009	EP2113563A2 Lipolytic enzyme variants
11/04/2009	EP2113561A1 Method and kit for rapid isolation of human Foxp3+ Treg cells
11/04/2009	EP2113560A1 Compositions for treating an arthritic condition
11/04/2009	EP2113516A1 Antibodies against C5 inhibiting type II endothelial cell activation
11/04/2009	EP2113254A1 Compositions for treating an inflammatory auto-immune condition
11/04/2009	EP1730264B1 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture
11/04/2009	EP1721976B1 Modified promoter
11/04/2009	EP1700913B1 Fluorescent proteins
11/04/2009	EP1650295B1 Process for producing tissue cell from pluripotent stem cell derived from iris pigment epithelial cell of animal and tissue cell obtained by the process
11/04/2009	EP1250599B1 System for the internal qualitative and quantitative validation of marker indices
11/04/2009	EP1159421B1 Human suppressor of fused
11/04/2009	EP1105500B1 Selection method
11/04/2009	EP1032660B1 Method of identifying binding site domains that retain the capacity of binding to an epitop
11/04/2009	EP1004299B1 Vaccine precursors, vaccines for treating tumors
11/03/2009	US7612269 Rice cultivar calmati-202
11/03/2009	US7612262 Inbred maize variety PHEKN
11/03/2009	US7612260 Plants and seeds of corn variety LH363
11/03/2009	US7612259 Soybean variety D4127789
11/03/2009	US7612258 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof
11/03/2009	US7612257 Modulate dihydrokaempferol (DHK), dihydroquercetin (DHQ), naringenin and eriodictyol metabolism; transgenic plants; roses
11/03/2009	US7612250 Nuclear transfer embryo formation method
11/03/2009	US7612194 Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
11/03/2009	US7612190 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy
11/03/2009	US7612167 Human hematopoietic growth regulatory gene product
11/03/2009	US7612164 Cardiac muscle function and manipulation
11/03/2009	US7612059 Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
11/03/2009	US7612044 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/03/2009	US7612042 Using soluble isoform of estrogen receptor as heregulin inhibiting therapeutic for use in treatment and prevention of breast and prostate cancer; competitive binding; gene therapy
11/03/2009	US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009	US7611904 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
11/03/2009	US7611897 AP1 amine oxidase variants
11/03/2009	US7611896 Protein-free medium comprising agent that balances the oncotic pressure across semipermeable cell membranes for use detecting parasitic infection; immunodiagnostics
11/03/2009	US7611895 Culturing eye tissues for treatment of vision defects; tissue engineering; grafting/surgery
11/03/2009	US7611894 Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and use
11/03/2009	US7611885 Pharmaceutically compatible method for purifying intact bacterial minicells
11/03/2009	US7611882 High performance in detergent compositions; superior cleaning and stain removal; cleaning a fabric, a dishware or hard surface
11/03/2009	US7611881 Due to one or more amino acid modifications in a xylanase polypeptide or fragment produces a variant xylanase polypeptide which has an altered sensitivity to a xylanase inhibitor as compared with the parent enzyme
11/03/2009	US7611865 Genetic engineering
11/03/2009	US7611855 Permits accurate assay of a target substance in a specimen by the use of two types of characteristic antibodies
11/03/2009	US7611852 Using heart cells as models for screening and identifying potassium channel modulators as well as treat and prevent long qt syndrome and cardiovascular disorders
11/03/2009	US7611832 Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
11/03/2009	CA2418961C Anti-il-12 antibodies, compositions, methods and uses
11/03/2009	CA2418442C Novel helper functions for recombinant vector production
11/03/2009	CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009	CA2289611C Method for the production of non-group c adenoviral vectors
11/03/2009	CA2198497C Acetohydroxyacid synthase promoter for expression of introduced genes in plants
11/03/2009	CA2191064C Pantropic neurotrophic factors
11/03/2009	CA2105618C Humanized antibodies to ganglioside gm2
10/2009
10/29/2009	WO2009132251A2 Methods and compositions comprising anti-idiotypic antibodies to anti-mmp-14 antibodies
10/29/2009	WO2009132220A2 Isoprene synthase variants for improved microbial production of isoprene
10/29/2009	WO2009132195A1 Immortal avian cell line and methods of use
10/29/2009	WO2009132156A1 Retinal pigment epithelial stem cells
10/29/2009	WO2009132083A2 Compositions and methods for promoting the generation of pdx1+ pancreatic cells
10/29/2009	WO2009132068A2 Treatment of pluripotent cells
10/29/2009	WO2009132063A2 Pluripotent cells
10/29/2009	WO2009131958A2 Compounds, compositions and methods comprising triazine derivatives
10/29/2009	WO2009131954A2 Compounds, compositions and methods comprising oxadiazole derivatives
10/29/2009	WO2009131951A2 Compounds, compositions and methods comprising isoxazole derivatives
10/29/2009	WO2009131947A2 Compounds, compositions and methods comprising pyridazine derivatives
10/29/2009	WO2009131909A2 Recombinant deamidated gliadin antigen
10/29/2009	WO2009131568A1 Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
10/29/2009	WO2009131262A1 Method of manufacturing induced pluripotent stem cell originated from human somatic cell
10/29/2009	WO2009131256A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
10/29/2009	WO2009131239A1 Stable polyvalent antibody
10/29/2009	WO2009131203A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus
10/29/2009	WO2009130845A1 Multi-axis rotary stirring device and method of producing cultured cells by using the same
10/29/2009	WO2009130598A1 Genetically modified eukaryotic cells
10/29/2009	WO2009130307A1 Cytoplasmic male sterile rucola
10/29/2009	WO2009129743A1 Gif1 promoter and uses thereof

1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 1827